EUVIMEDEUVIMED entdecken
LeserbriefFallbericht

Prevention of amputation by neoadjuvant therapy with pembrolizumab in acrolentiginous melanoma

Inga Hansen, Alessandra Rünger, Clara Noebel, Glenn Geidel iD, Julian Kött iD, Anne Menz, Lina Hildebrandt, Stefan W Schneider, Christoffer Gebhardt iD

Journal of the European Academy of Dermatology and Venereology · 2024

DOI: 10.1111/jdv.19920 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, 2024. Verfasst von Inga Hansen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venereology, University Skin Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Hauptthemen laut MEDLINE: Amputation, Surgical, Antibodies, Monoclonal, Humanized, Melanoma, Neoadjuvant Therapy. Die Arbeit nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amputation, SurgicalAntibodies, Monoclonal, HumanizedMelanomaNeoadjuvant TherapySkin NeoplasmsHumansAntineoplastic Agents, Immunological

Substanzen

Antibodies, Monoclonal, HumanizedAntineoplastic Agents, Immunologicalpembrolizumab

Autor:innen und Institutionen

  • Department of Dermatology and Venereology, University Skin Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Institute of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

ORCID-Profile: Glenn Geidel, Julian Kött, Christoffer Gebhardt

Zitieren

APA

Hansen, I., Rünger, A., Noebel, C., Geidel, G., Kött, J., Menz, A., Hildebrandt, L., Schneider, S. W., & Gebhardt, C. (2024). Prevention of amputation by neoadjuvant therapy with pembrolizumab in acrolentiginous melanoma. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19920

Vancouver

Hansen I, Rünger A, Noebel C, Geidel G, Kött J, Menz A, et al. Prevention of amputation by neoadjuvant therapy with pembrolizumab in acrolentiginous melanoma. Journal of the European Academy of Dermatology and Venereology. 2024. doi:10.1111/jdv.19920

BibTeX
@article{Hansen2024,
  author = {Hansen, Inga and Rünger, Alessandra and Noebel, Clara and Geidel, Glenn and Kött, Julian and Menz, Anne and Hildebrandt, Lina and Schneider, Stefan W and Gebhardt, Christoffer},
  title = {Prevention of amputation by neoadjuvant therapy with pembrolizumab in acrolentiginous melanoma},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2024},
  doi = {10.1111/jdv.19920}
}
Kostenlos starten →